Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0001438133-25-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-27 | 2025-02-25 | TNDM | Sheridan John F | Pres, CEO, Dir | M - OptEx | $0.00 | +32.8K | 66.4K | +98% | $0 |
| DM | 2025-02-27 | 2025-02-25 | TNDM | Sheridan John F | Pres, CEO, Dir | F - Tax | $33.34 | -13.4K | 79.0K | -15% | -$447.7K |
| DM | 2025-02-27 | 2025-02-25 | TNDM | Sheridan John F | Pres, CEO, Dir | M - OptEx | $0.00 | -32.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | M | A | 26,047 | $0.00 | 89,017 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-25 | F | D | 3,419 | $33.34 | 62,970 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-25 | M | A | 6,732 | $0.00 | 66,389 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-25 | F | D | 10,008 | $33.34 | 79,009 | D | — | — | |
| 5 | Derivative | Performance Stock Unit | 2025-02-25 | M | D | 6,732 | $0.00 | 0 | D | — · — to — | 6,732 Common Stock | (F2) Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). (F3) Each PSU represents a contingent right to receive one share of the Company common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the Measurement Date). The number of shares issued may range from 0% to 200% of the base grant amount, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. |
| 6 | Derivative | Performance Stock Unit | 2025-02-25 | M | D | 26,047 | $0.00 | 0 | D | — · — to — | 26,047 Common Stock | (F4) Awarded on May 25, 2022 pursuant to the 2013 Plan. (F3) Each PSU represents a contingent right to receive one share of the Company common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the Measurement Date). The number of shares issued may range from 0% to 200% of the base grant amount, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. |